Biocon Ltd.

Syngene International extends research collaboration with Bristol Myers Squibb through 2035, expanding drug development services.

Biocon raises Rs 4,150 crore through QIP. Funds to buy Mylan (Viatris) stake in Biocon Biologics. Focus on biosimilars, diabetes, oncology.

Biocon Pharma receives USFDA approval for generic Everolimus tablets, used to treat tuberous sclerosis complex (TSC).

Biocon Biologics to launch Trastuzumab, Nivolumab, Pembrolizumab biosimilars for cancer. Expanding oncology portfolio. Details here.

Biocon out-licenses its diabetes drug Semaglutide to Ajanta Pharma for export to 23 countries in Africa, Middle East & Central Asia.

Amagi Media Labs shares debut weakly, settling nearly 4% lower than the IPO price. IPO subscribed 30.22 times.

Stock markets decline for 3rd day due to geopolitical tensions. Sensex sinks below 82k. Foreign fund outflows add pressure.

Pesticide industry urges tighter e-commerce rules to curb fake product sales. Calls for mandatory authorization to protect farmers.

Rupee crashes to a record low of 91.73 against the US dollar amid foreign fund outflows and global uncertainty. Key factors explained.

NBSL, ASI discuss BHIM-UPI for ticket bookings at heritage sites. Cashbacks mulled. UPI QR code payments coming soon.

Amagi Media Labs shares debut weakly, settling nearly 4% lower than the IPO price. IPO subscribed 30.22 times.

Stock markets decline for 3rd day due to geopolitical tensions. Sensex sinks below 82k. Foreign fund outflows add pressure.

Pesticide industry urges tighter e-commerce rules to curb fake product sales. Calls for mandatory authorization to protect farmers.

Rupee crashes to a record low of 91.73 against the US dollar amid foreign fund outflows and global uncertainty. Key factors explained.

Cumin secures $5M funding led by Fireside Ventures. Arthum bags Rs 10 cr, V6 Clinics raises $2M for expansion and AI platform.